Clinical Trials Overall Report
Date: 20.09.2023
Name of the extract: Valor Humani.
Duration of trial – 4 months (07–10. 2023 year)
Short summary: Primary conclusion of investigators are following:
-
Valor Humani is highly effective of patients with middle part GI tract tumors. Patients with Fater’s papilla cancer, liver malignancies, pancreatic cancer is well sensative.
First two months of follow-up has shown that two poor-condition patients diagnosed with Fater’s cancer recieving palliative chemo is clinically improved. Patients gained the weight, appetite has improved, become more active. Instrumental investigation has also shown that tumor size shrinked and no regional metastases. Five more patients are included to the second part of the follow-up with GI tract cancer and they have started the treatment with Valor Humani. -
There no side effect from Valor Humani has been found during these two months, patients just complained on unusual taste.
-
Valor Humani could be used simualteously with chemotreatment and it would not influence to the effectiveness of the chemo and target treatment.
Dr. Raufov Farkhod Makhmudovich
Summary of 4 months trial period on Valor Humani (08–12/2023y)
Date: 03.09.2024
Follow up conclusion of 4 moths trial of 2023 y:
15 patient were included into pilot trial of 2023 year and duration of grand was 4 months (from August to December of 2023 y). Patient with advanced stages of the disease were included on the investigation. There were follow up after the 1 year all those patient and were considered the opinion of patients. There are no long term side effect from Valor Humani has been found. Patient 1, Patient 2, Patient 3, Patient 4, Patient 5, Patient 6, Patient 7, Patient 8 – in total 8 patients unfortunately are passed away. Patient 9, Patient 10, Patient 11, Patient 12, Patient 13, Patient 14, Patient 15 – in total 7 patients are alive and some continuing the special treatment. All those 7 patients informing that their overall condition is good and some taking special and symptomatic treatment. Also some patients have shown interest to continue the treatment with Valor Humani. Overall conclusion from the trial after the 1 year follow up period is positive and Valor Humani extract were recommended to all those 7 patients as a additional component to their treatment.
Signature: Dr. Raufov F.M.
Download:
Clinical Trials Overall Report
Summary of 4 months trial period on Valor Humani (08-122023y)